Seed company Monsanto Co, which rejected Bayer AG’s buyout offer in May, is exploring various transactions, including the acquisition of BASF’s agriculture-solutions unit, Bloomberg reported.
In return, BASF would likely receive newly issued shares in Monsanto, Bloomberg said, citing people familiar with the matter.
The discussions are at an early stage, and no final decisions have been made, the report said, citing the people. Talks with Bayer are continuing, sources told Bloomberg.
Monsanto and BASF could not be reached for comment outside regular business hours.
A Bayer spokesman said the company did not comment on rumors or speculation.
Monsanto’s board is split over the merit of potential deals with rivals BASF and Bayer with some executives keen to remain independent and others preferring a takeover, Bloomberg reported, citing a source.
By Subrat Patnaik
Source: Reuters
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.
